Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30986% above fair value
$32.13−0.03 (-0.09%)
Close on Nov 19, 2026Market cap $1.20BP/E –Yield –
Harrow gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Harrow's gross profit for the twelve months ending Jun 30, 2026 was $201.96M, up 19.0% year over year. For fiscal 2025 it was $204.37M, up 35.9% from the year before. Over ten years it grew 46.4% a year on average. The highest annual figure on record is $204.37M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $204.37M | +35.9% |
| FY2024 | Dec 31, 2024 | $150.37M | +66.1% |
| FY2023 | Dec 31, 2023 | $90.55M | +43.3% |
| FY2022 | Dec 31, 2022 | $63.21M | +16.5% |
| FY2021 | Dec 31, 2021 | $54.26M | +57.7% |
| FY2020 | Dec 31, 2020 | $34.41M | -0.0% |
| FY2019 | Dec 31, 2019 | $34.42M | +38.5% |
| FY2018 | Dec 31, 2018 | $24.85M | +87.3% |
| FY2017 | Dec 31, 2017 | $13.27M | +31.2% |
| FY2016 | Dec 31, 2016 | $10.11M | +124.2% |
| FY2015 | Dec 31, 2015 | $4.51M | +695.4% |
| FY2014 | Dec 31, 2014 | $567.00K | +5570.0% |
| FY2013 | Dec 31, 2013 | $10.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $50.36M | +6.0% |
| Q1 FY2026 | Mar 31, 2026 | $27.05M | -16.3% |
| Q4 FY2025 | Dec 31, 2025 | $70.62M | +34.0% |
| Q3 FY2025 | Sep 30, 2025 | $53.93M | +44.8% |
| Q2 FY2025 | Jun 30, 2025 | $47.51M | +30.5% |
| Q1 FY2025 | Mar 31, 2025 | $32.31M | +34.4% |
| Q4 FY2024 | Dec 31, 2024 | $52.70M | +110.3% |
| Q3 FY2024 | Sep 30, 2024 | $37.24M | +53.9% |
| Q2 FY2024 | Jun 30, 2024 | $36.40M | +55.1% |
| Q1 FY2024 | Mar 31, 2024 | $24.03M | +34.8% |
| Q4 FY2023 | Dec 31, 2023 | $25.05M | +76.9% |
| Q3 FY2023 | Sep 30, 2023 | $24.20M | +50.3% |
| Q2 FY2023 | Jun 30, 2023 | $23.47M | +39.8% |
| Q1 FY2023 | Mar 31, 2023 | $17.83M | +10.4% |
| Q4 FY2022 | Dec 31, 2022 | $14.16M | -6.2% |
| Q3 FY2022 | Sep 30, 2022 | $16.10M | +17.0% |
| Q2 FY2022 | Jun 30, 2022 | $16.79M | +22.4% |
| Q1 FY2022 | Mar 31, 2022 | $16.16M | +38.4% |
| Q4 FY2021 | Dec 31, 2021 | $15.11M | +41.8% |
| Q3 FY2021 | Sep 30, 2021 | $13.76M | +28.6% |
| Q2 FY2021 | Jun 30, 2021 | $13.72M | +182.5% |
| Q1 FY2021 | Mar 31, 2021 | $11.67M | +42.5% |
| Q4 FY2020 | Dec 31, 2020 | $10.66M | +17.9% |
| Q3 FY2020 | Sep 30, 2020 | $10.70M | +23.1% |
| Q2 FY2020 | Jun 30, 2020 | $4.86M | -41.4% |
| Q1 FY2020 | Mar 31, 2020 | $8.19M | -2.4% |
| Q4 FY2019 | Dec 31, 2019 | $9.04M | +24.1% |
| Q3 FY2019 | Sep 30, 2019 | $8.69M | +32.8% |
| Q2 FY2019 | Jun 30, 2019 | $8.29M | +33.1% |
| Q1 FY2019 | Mar 31, 2019 | $8.39M | +75.1% |
| Q4 FY2018 | Dec 31, 2018 | $7.28M | +87.7% |
| Q3 FY2018 | Sep 30, 2018 | $6.55M | +112.6% |
| Q2 FY2018 | Jun 30, 2018 | $6.23M | +74.5% |
| Q1 FY2018 | Mar 31, 2018 | $4.79M | +75.0% |
| Q4 FY2017 | Dec 31, 2017 | $3.88M | +42.5% |
| Q3 FY2017 | Sep 30, 2017 | $3.08M | +22.1% |
| Q2 FY2017 | Jun 30, 2017 | $3.57M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.74M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.72M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.52M | – |
See a number that looks wrong?